Health Condition 1: B338- Other specified viral diseases
Conditions
Interventions
Intervention1: Ivermectin: Cases of COVID 19 shall be
treated with Ivermectin 200 to 400mcg per kg body weight on day 1 and day 2 along with
standard treatment of the hospital protocol
Control Interve
Sponsors
Max Super Speciality Hospital A Unit of Devki Devi Foundation
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects within age group between 18 to 75 years 2. With either sex, male or female 3. Confirmed case of COVID-19 at Max Hospitals.
Exclusion criteria
Exclusion criteria: Patients who are critically sick
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This study aims to confirm the antivirus effectiveness of Ivermectin on coronavirus i.e COVID 19 then to explore its potential use in the combating to the COVID 19 pandemics.Timepoint: Viral load will be monitored at 1, 3 & 5 days from beginning of trial drug (48 hours interval) Until the report comes negative. Drug will be delivered on daily basis upto eradication of virus or completion of the trial | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety of the drug vs standard care of treatment will be checkedTimepoint: Treatment will be provided until the eradication of virus or completion of the trial. | — |
Countries
India
Contacts
Public ContactRajesh Saxena
Internal Medicine, Max Super Speciality Hospital (DDF), Saket
Outcome results
None listed